Matches in Wikidata for { <http://www.wikidata.org/entity/Q37339612> ?p ?o ?g. }
- Q37339612 description "article científic" @default.
- Q37339612 description "article scientifique" @default.
- Q37339612 description "articolo scientifico" @default.
- Q37339612 description "artigo científico" @default.
- Q37339612 description "artículu científicu espublizáu en 2012" @default.
- Q37339612 description "bilimsel makale" @default.
- Q37339612 description "scientific article published on 24 June 2012" @default.
- Q37339612 description "vedecký článok" @default.
- Q37339612 description "vetenskaplig artikel" @default.
- Q37339612 description "videnskabelig artikel" @default.
- Q37339612 description "vědecký článek" @default.
- Q37339612 description "wetenschappelijk artikel" @default.
- Q37339612 description "wissenschaftlicher Artikel" @default.
- Q37339612 description "наукова стаття, опублікована в червні 2012" @default.
- Q37339612 description "научни чланак" @default.
- Q37339612 description "مقالة علمية نشرت في 24 يونيو 2012" @default.
- Q37339612 name "Elevated baseline CA19-9 levels correlate with adverse prognosis in patients with early- or advanced-stage pancreas cancer" @default.
- Q37339612 name "Elevated baseline CA19-9 levels correlate with adverse prognosis in patients with early- or advanced-stage pancreas cancer" @default.
- Q37339612 name "Elevated baseline CA19-9 levels correlate with adverse prognosis in patients with early- or advanced-stage pancreas cancer" @default.
- Q37339612 type Item @default.
- Q37339612 label "Elevated baseline CA19-9 levels correlate with adverse prognosis in patients with early- or advanced-stage pancreas cancer" @default.
- Q37339612 label "Elevated baseline CA19-9 levels correlate with adverse prognosis in patients with early- or advanced-stage pancreas cancer" @default.
- Q37339612 label "Elevated baseline CA19-9 levels correlate with adverse prognosis in patients with early- or advanced-stage pancreas cancer" @default.
- Q37339612 prefLabel "Elevated baseline CA19-9 levels correlate with adverse prognosis in patients with early- or advanced-stage pancreas cancer" @default.
- Q37339612 prefLabel "Elevated baseline CA19-9 levels correlate with adverse prognosis in patients with early- or advanced-stage pancreas cancer" @default.
- Q37339612 prefLabel "Elevated baseline CA19-9 levels correlate with adverse prognosis in patients with early- or advanced-stage pancreas cancer" @default.
- Q37339612 P1433 Q37339612-6FEA527F-64CC-43C3-ADFA-D17452330BD7 @default.
- Q37339612 P1476 Q37339612-D62566BC-DA88-49A6-A8D0-341D60443167 @default.
- Q37339612 P2093 Q37339612-1E7736C9-DD84-4A1F-814D-90DD6E0D59AA @default.
- Q37339612 P2093 Q37339612-D59EFF5A-BE13-42EA-93B4-1BC3BB409B3A @default.
- Q37339612 P2860 Q37339612-03196D46-B143-40B0-8CB3-68CB7FC78F25 @default.
- Q37339612 P2860 Q37339612-083BFA75-0825-40CE-9EFD-A436837B1D6D @default.
- Q37339612 P2860 Q37339612-0F05D699-98A5-4C0C-A54C-A31D0EE9911B @default.
- Q37339612 P2860 Q37339612-12350185-3D9B-4A37-BB64-F0D344B7D56C @default.
- Q37339612 P2860 Q37339612-15774D37-90A3-4410-AABB-F9367827F2EA @default.
- Q37339612 P2860 Q37339612-161954AC-FFD0-44AD-B1FE-DE499EC09152 @default.
- Q37339612 P2860 Q37339612-19A0BBB0-7BA0-4851-B8AF-152C49A56869 @default.
- Q37339612 P2860 Q37339612-26F9843B-DAC6-4500-86AB-073090938D15 @default.
- Q37339612 P2860 Q37339612-274C6D49-82EC-4C1E-B6D0-DABAF53B8323 @default.
- Q37339612 P2860 Q37339612-29404D78-C5AA-4EA9-9850-C2B078669805 @default.
- Q37339612 P2860 Q37339612-30162C73-4BD7-437A-8096-5D4C13A64632 @default.
- Q37339612 P2860 Q37339612-38122CD6-4B59-40D9-A877-BC6F68E9811F @default.
- Q37339612 P2860 Q37339612-3FD9DE91-6799-4942-9C65-72652828A926 @default.
- Q37339612 P2860 Q37339612-40DA9483-04B4-4327-A35F-27B730DE7CA7 @default.
- Q37339612 P2860 Q37339612-47322DEA-5944-4A53-927E-F170CB07692F @default.
- Q37339612 P2860 Q37339612-49051557-620B-4EC7-8C69-46B742484FF4 @default.
- Q37339612 P2860 Q37339612-4AE40E5B-07BC-40E0-BCCE-CE1AA04B320B @default.
- Q37339612 P2860 Q37339612-508B0459-4ADF-4160-A666-9F43BAF3E0D3 @default.
- Q37339612 P2860 Q37339612-50B2E0EE-43A6-483D-918B-FC3D9352C642 @default.
- Q37339612 P2860 Q37339612-5F02D75C-D021-434C-907B-3959F15692F6 @default.
- Q37339612 P2860 Q37339612-717EB4AC-DDD1-4E4E-90C0-465DDBE05710 @default.
- Q37339612 P2860 Q37339612-7476ABAC-1BC6-47D1-B796-55D4C1AF7A4F @default.
- Q37339612 P2860 Q37339612-78839418-55AF-443F-9311-994E1867E413 @default.
- Q37339612 P2860 Q37339612-8D5CBFB1-D2BE-4C43-A88E-E9266C20EF02 @default.
- Q37339612 P2860 Q37339612-96C3D6ED-FCA4-4913-9583-E3468EB8509B @default.
- Q37339612 P2860 Q37339612-98162E2D-8417-42B3-851E-C69E43AF2FBC @default.
- Q37339612 P2860 Q37339612-98D1DB53-EFE2-43BB-9289-F08F713A7A22 @default.
- Q37339612 P2860 Q37339612-99F55D80-EDB5-4EA2-9D23-6CBCC613DDB5 @default.
- Q37339612 P2860 Q37339612-9BE23C86-12B6-4654-8A54-1302ACFF68A1 @default.
- Q37339612 P2860 Q37339612-9F4DE4DA-58E2-4293-9715-A3DFCD3FCCB3 @default.
- Q37339612 P2860 Q37339612-ABAFEC9A-F835-4F0E-ACC2-3C72FAA403DA @default.
- Q37339612 P2860 Q37339612-B1FC2B8B-99CB-4FA9-B86F-50C01E02DBDB @default.
- Q37339612 P2860 Q37339612-B27F6640-FA5C-4540-8B25-12C260FCFD2A @default.
- Q37339612 P2860 Q37339612-BFC5E611-752A-453C-A98C-4ED20ADD8A59 @default.
- Q37339612 P2860 Q37339612-DE4096CD-0931-4C11-93AB-8A44D13227A6 @default.
- Q37339612 P2860 Q37339612-E01E2415-19C1-4227-8580-7DB753F8A97B @default.
- Q37339612 P2860 Q37339612-E1BA1526-94F0-4F08-888B-776E2FA2E640 @default.
- Q37339612 P2860 Q37339612-E592A30C-748E-4E9B-A29F-AA179ADC4EAB @default.
- Q37339612 P2860 Q37339612-E8086829-DF46-4761-B31F-C27C2E3779D9 @default.
- Q37339612 P2860 Q37339612-F424FAA9-8E3E-4B8B-BB16-71616BA6B462 @default.
- Q37339612 P2860 Q37339612-F75F6025-B7B1-4F34-8A86-2A05368222E1 @default.
- Q37339612 P2888 Q37339612-00373744-8093-4F2F-8CB8-84687C4A52A4 @default.
- Q37339612 P304 Q37339612-23F8B0D3-17A4-40FA-9352-C472E0398AC4 @default.
- Q37339612 P31 Q37339612-458F320C-55EB-4599-A01D-D1386B97B3E0 @default.
- Q37339612 P356 Q37339612-F9B443AA-A3B0-4323-A479-1F86D7DE791C @default.
- Q37339612 P433 Q37339612-B7FF42A5-5D68-4238-AA40-56323C2EAA1E @default.
- Q37339612 P478 Q37339612-1F876B7F-3AEA-40CB-98A3-D6C4C426B043 @default.
- Q37339612 P50 Q37339612-40B7F366-5F7E-4F22-AD2D-13DCBB0FFCFD @default.
- Q37339612 P50 Q37339612-7C2913A0-955A-42E3-91ED-F909F1CFF426 @default.
- Q37339612 P577 Q37339612-AF950621-B974-4D5C-AE5A-8440E674990F @default.
- Q37339612 P698 Q37339612-36D9ACA3-9ED6-42F0-8E3D-E836E51670CB @default.
- Q37339612 P921 Q37339612-296BC1AE-52EA-4F4B-833A-29DF79A3EDFC @default.
- Q37339612 P932 Q37339612-040ECEDD-EA86-4BF6-92B9-0504D698581E @default.
- Q37339612 P356 S12032-012-0278-9 @default.
- Q37339612 P698 22729400 @default.
- Q37339612 P1433 Q2152666 @default.
- Q37339612 P1476 "Elevated baseline CA19-9 levels correlate with adverse prognosis in patients with early- or advanced-stage pancreas cancer" @default.
- Q37339612 P2093 "Elizabeth Trolli" @default.
- Q37339612 P2093 "Lai Wei" @default.
- Q37339612 P2860 Q27860525 @default.
- Q37339612 P2860 Q28131668 @default.
- Q37339612 P2860 Q28261984 @default.
- Q37339612 P2860 Q33367733 @default.
- Q37339612 P2860 Q33385281 @default.
- Q37339612 P2860 Q33686700 @default.
- Q37339612 P2860 Q34522003 @default.
- Q37339612 P2860 Q34557866 @default.
- Q37339612 P2860 Q34568471 @default.
- Q37339612 P2860 Q34570210 @default.
- Q37339612 P2860 Q34579882 @default.